Battle against malaria strengthened
DFID’s drive to halve deaths from malaria in at least 10 high-burden countries by 2015, as well as to save the lives of at least 50,000 women and 250,000 babies during childbirth, has been strengthened by a mid-term review of two frameworks guiding DFID’s work in these fields.
As a part of the Global Evaluations Framework Agreement (GEFA) DFID contracted e-Pact, a consortium that includes OPM, to carry out an evaluability assessment and mid-term review of these two frameworks. Of the recommendations made by e-Pact, six were accepted, and three were partially accepted.
Recommendations that were accepted, and how DFID responded to them, included
- Assess and strengthen relevant national data systems: DFID’s Africa Regional Malaria Programme is supporting effort to establish a more systematic approach to collating, managing and using information for malaria control to help define priorities for malaria control and maximize the results. DFID has supported efforts to improve vital registration, strengthen routine health information systems and undertake surveys.
- Build on success and innovation in Reproductive and Maternal Newborn Health (RMNH) programmes: Evaluations of some RMNH and malaria programmes are underway.
- Regularly review the epidemiological situation of malaria and support provided by country: Through its Africa Regional Malaria Programme DFID is supporting 22 African countries to select the optimal mix of interventions based on a better understanding of their epidemiological situation and local context.
- Strengthen the Malaria Results Tracker: The Malaria Results Tracker was updated following the National Audit Office Report on DFID’s malaria programmes.
- Incorporate logframes into DFID’s project management system: This recommendation refers to incorporating logframes into DFID’s central aid management system (ARIES).
- Strengthen the analysis and monitoring of value for money (VfM): DFID’s Research and Evidence Division has established a working group on assessing VfM and the rates of return from research including malaria.
The full evaluation, and DFID’s response to its recommendations, can be found below: